Paving the way to precision medicine: a single-cell sequencing perspective

Single-cell sequencing (scSeq) is transforming disease research by revealing the intricate diversity across cell populations, uncovering crucial biomarkers and therapeutic targets often masked by bulk approaches. This technique has been particularly impactful in cancer research, where it has advanced our understanding of tumor biology, paving the way for more targeted and effective treatments and, ultimately, precision healthcare.

 

Despite technology advances, which have rapidly boosted the adoption of single-cell sequencing experiments by increasing the number of cells analyzed and reducing the cost and complexity, many laboratories still struggle to incorporate this technique into their routine investigations.

 

Join the panel discussion to hear industry experts discuss how they are addressing some of the challenges posed by scSeq.

 

Learning Objectives